Influenza Medications Market Demand, Share and Future Outlook 2034
Global Influenza Medications Market Growth, Size, Trends Analysis - By Type, By Distribution Channel - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: May-2025 | Report ID: PHAR2509 | Pages: 1 - 235 | Formats*: |
| Category : Pharmaceutical | |||
According to SPER Market Research, the Global Influenza Medications Market is estimated to reach USD 2022.56 million by 2034 with a CAGR of 7.33%.
Influenza Medications Market Introduction and Overview
The report includes an in-depth analysis of the Global Influenza Medications Market, including market size and trends, product mix, Applications, and supplier analysis. The influenza medication market is expected to increase at a compound annual growth rate (CAGR) of 7.33% between 2025 and 2034, from its estimated USD 996.99 million in 2024. The need for influenza drugs is expected to rise globally due to the rising incidence of influenza. The market for influenza medications is expected to see prosperous opportunities due to the ageing population and increased focus on R&D initiatives to introduce novel medications and treatments.
By Type Insights
The vaccination category dominated the market in 2024. The growth is due to ongoing research and breakthroughs in influenza vaccinations. The CDC conducts annual trials to determine the efficacy of influenza (flu) vaccinations in preventing flu. Recent research suggests that flu vaccination reduces the risk of flu illness by 50% to 60% across the population during seasons when the circulating flu viruses closely match those used in vaccine manufacture. When it comes to influenza B and influenza A (H1N1) viruses, current vaccines are more effective.
By Distribution Channel Insights
The online pharmacy segment is predicted to grow at the quickest CAGR throughout the forecast period. Online pharmacies are driving growth in the influenza drugs market by providing customers with easy and accessible channels for purchasing healthcare items.
Regional Insights
The substantial yearly burden of influenza infections is the reason why North America led the market for influenza drugs in 2024. Population density, international travel, and seasonal fluctuations are some of the factors that are causing influenza viruses to spread widely, which is driving up demand for influenza medications. The region's market will grow even more thanks to the sophisticated medical facilities and well-established healthcare infrastructure, which includes clinics, hospitals, and pharmacies.
Get more information on this report: Download Free Sample PDF
Market Competitive Landscape
There are a number of major companies in the influenza drug market that are vying for customers' attention in an effort to provide efficient treatments and influenza prevention strategies. To stay ahead of the competition, market participants are always launching new products, collaborating, and innovating.
Recent Developments:
- Mylab and Ekincare launched a strategic partnership in November 2023 to promote an anti-influenza nasal vaccine. The collaboration enables the corporations to incorporate the vaccine, created by the Serum Institute of India (SII), into their healthcare plans, ensuring that the vaccination reaches a large population base.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Type, By Distribution Channel |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | Biondvax, Daiichi Sankyo Company, Hoffmann-La Roche Ltd (Genentech USA, Inc), GlaxoSmithKline, Genentech USA, Inc, NATCO Pharma Limited, Novartis AG, Sanofi, Seqirus, Shionogi & Co, Ltd. |
Key Topics Covered in the Report
- Global Influenza Medications Market Size (FY’2021-FY’2034)
- Overview of Global Influenza Medications Market
- Segmentation of Global Influenza Medications Market By Type (Antiviral Drugs, Antihistamines, Vaccines, Other)
- Segmentation of Global Influenza Medications Market By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
- Statistical Snap of Global Influenza Medications Market
- Expansion Analysis of Global Influenza Medications Market
- Problems and Obstacles in Global Influenza Medications Market
- Competitive Landscape in the Global Influenza Medications Market
- Details on Current Investment in Global Influenza Medications Market
- Competitive Analysis of Global Influenza Medications Market
- Prominent Players in the Global Influenza Medications Market
- SWOT Analysis of Global Influenza Medications Market
- Global Influenza Medications Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
2. Research Methodology
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
5. Market variable and outlook
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
6. Competitive Landscape
- 6.1. Global Influenza Medications Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Influenza Medications Market
7. Global Influenza Medications Market, By Type (USD Million) 2021-2034
- 7.1. Antiviral Drugs
- 7.2. Antihistamines
- 7.3. Vaccines
- 7.4. Other
8. Global Influenza Medications Market, By Distribution Channel (USD Million) 2021-2034
- 8.1. Hospital Pharmacies
- 8.2. Retail Pharmacies
- 8.3. Online Pharmacies
9. Global Influenza Medications Market, (USD Million) 2021-2034
- 9.1. Global Influenza Medications Market Size and Market Share
10. Global Influenza Medications Market, By Region, (USD Million) 2021-2034
- 10.1. Asia-Pacific
- 10.1.1. Australia
- 10.1.2. China
- 10.1.3. India
- 10.1.4. Japan
- 10.1.5. South Korea
- 10.1.6. Rest of Asia-Pacific
- 10.2. Europe
- 10.2.1. France
- 10.2.2. Germany
- 10.2.3. Italy
- 10.2.4. Spain
- 10.2.5. United Kingdom
- 10.2.6. Rest of Europe
- 10.3. Middle East and Africa
- 10.3.1. Kingdom of Saudi Arabia
- 10.3.2. United Arab Emirates
- 10.3.3. Qatar
- 10.3.4. South Africa
- 10.3.5. Egypt
- 10.3.6. Morocco
- 10.3.7. Nigeria
- 10.3.8. Rest of Middle-East and Africa
- 10.4. North America
- 10.4.1. Canada
- 10.4.2. Mexico
- 10.4.3. United States
- 10.5. Latin America
- 10.5.1. Argentina
- 10.5.2. Brazil
- 10.5.3. Rest of Latin America
11. Company Profile
- 11.1. Biondvax
- 11.1.1. Company details
- 11.1.2. Financial outlook
- 11.1.3. Product summary
- 11.1.4. Recent developments
- 11.2. Daiichi Sankyo Company
- 11.2.1. Company details
- 11.2.2. Financial outlook
- 11.2.3. Product summary
- 11.2.4. Recent developments
- 11.3. Hoffmann-La Roche Ltd (Genentech USA, Inc)
- 11.3.1. Company details
- 11.3.2. Financial outlook
- 11.3.3. Product summary
- 11.3.4. Recent developments
- 11.4. GlaxoSmithKline
- 11.4.1. Company details
- 11.4.2. Financial outlook
- 11.4.3. Product summary
- 11.4.4. Recent developments
- 11.5. Genentech USA, Inc
- 11.5.1. Company details
- 11.5.2. Financial outlook
- 11.5.3. Product summary
- 11.5.4. Recent developments
- 11.6. NATCO Pharma Limited
- 11.6.1. Company details
- 11.6.2. Financial outlook
- 11.6.3. Product summary
- 11.6.4. Recent developments
- 11.7. Novartis AG
- 11.7.1. Company details
- 11.7.2. Financial outlook
- 11.7.3. Product summary
- 11.7.4. Recent developments
- 11.8. Sanofi
- 11.8.1. Company details
- 11.8.2. Financial outlook
- 11.8.3. Product summary
- 11.8.4. Recent developments
- 11.9. Seqirus
- 11.9.1. Company details
- 11.9.2. Financial outlook
- 11.9.3. Product summary
- 11.9.4. Recent developments
- 11.10. Shionogi & Co., Ltd
- 11.10.1. Company details
- 11.10.2. Financial outlook
- 11.10.3. Product summary
- 11.10.4. Recent developments
- 11.11. Others
12. Conclusion
13. List of Abbreviations
14. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Influenza Medications Market is projected to reach USD 2022.56 million by 2034, growing at a CAGR of 7.33% during the forecast period.
Influenza Medications Market grew in Market size from 2025. The Market is expected to reach USD 2022.56 million by 2034, at a CAGR of 7.33% during the forecast period.
Influenza Medications Market CAGR of 7.33% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Influenza Medications Market size is USD 2022.56 million from 2025 to 2034.
Influenza Medications Market is covered By Type, By Distribution Channel
The North America is anticipated to have the highest Market share in the Influenza Medications Market.
Biondvax, Daiichi Sankyo Company, Hoffmann-La Roche Ltd (Genentech USA, Inc), GlaxoSmithKline, Genentech USA, Inc, NATCO Pharma Limited, Novartis AG, Sanofi, Seqirus, Shionogi & Co, Ltd.
The report includes an in-depth analysis of the Global Influenza Medications Market, including market size and trends, product mix, Applications, and supplier analysis
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
